Symptom Tracking App for Liver Cancer Immunotherapy
Part of Cancer, Digestive system clinical trials.
This trial tests whether using a smartphone app to regularly report your symptoms can help you and your doctor manage side effects better during immunotherapy treatment for liver cancer. It is a study where you would be randomly assigned to either use the app or receive usual care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with hepatocellular carcinoma (a type of liver cancer).
- You are currently receiving immunotherapy treatment.
- You are able and willing to use a smartphone or tablet to answer health questions.
- You can understand Mandarin Chinese.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using a smartphone app to regularly report how you're feeling can help monitor your well-being during cancer treatment. If you're starting a new cancer treatment soon and are comfortable using a smartphone app, you may be able to join.
This study tests a smartphone/tablet app that helps children who have finished cancer treatment and their caregivers manage early symptoms that may come back after treatment. It may help families track symptoms and get supportive guidance during the early survivorship period.
This study tests a smartphone app designed to help lung cancer patients track and manage side effects while receiving combination drug therapy at home. The app learns from your symptom patterns to provide personalized support during your treatment.
This trial tests if a behavioral intervention (like counseling or coaching) can help people with advanced liver cancer live longer. You and a caregiver would use a smartphone app to answer questions and follow the program.
This trial uses a smartphone app to track your symptoms during radiation treatment for head and neck cancer. It aims to help your care team catch problems early and improve your quality of life.
This study looks at a 29-gene test to see if it can predict how well liver cancer responds to targeted therapy plus immunotherapy. If you have liver cancer and are getting this type of treatment, your stored tumor sample might help researchers learn more.
Hear when a new Hepatocellular Carcinoma (HCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.